UMM Logo

Universitas Muhammadiyah Malang


Free Download Journals Directory


International Journal of Medical Sciences

.: Home > International Journal of Medical Sciences > 2008 > Volume 5 Number 3 > Antonio Cassio Assis Pellizzon, Joمo Salvajoli, Paulo Novaes, Maria Maia, Ricardo Fogaroli, Doglas Gides, Rodrigues Horriot

The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition

Antonio Cassio Assis Pellizzon, Joمo Salvajoli, Paulo Novaes, Maria Maia, Ricardo Fogaroli, Doglas Gides, Rodrigues Horriot
Abstract :

Purpose: To evaluated prognostic factors and impact of the quality of planning of high dose rate  rachytherapy (HDR-BT) for patients with local or locally advanced prostate cancer treated with external beam radiotherapy (EBRT) and HDR-BT. Methods and Materials: Between 1997 and 2005, 209 patients with biopsy proven prostate adenocarcinoma were treated with localized EBRT and HDR-BT at the Department of Radiation-Oncology, Hospital A. C. Camargo, Sao Paulo, Brazil. Patient’s age, Gleason score (GS), clinical stage (CS), initial PSA (iPSA), risk group for biochemical failure (GR), doses of EBRT and HDR-BT, use of three-dimensional planning for HDR-BT (3DHDR) and the Biological Effective Dose (BED) were evaluated as prognostic factors for biochemical control (bC). Results: Median age and median follow-up time were 68 and 5.3 years, respectively. Median EBRT and HDR-BT
doses were 45 Gy and 20 Gy. The crude bC at 3.3 year was 94.2%. For the Low, intermediate and high risk patients the bC rates at 3.3 years were 91.5%, 90.2% and 88.5%, respectively. Overall survival (OS) and disease specific survival rates at 3.3 years were 97.8% and 98.4%, respectively. On univariate analysis the prognostic factors related bC were GR (p= 0.040), GS < 6 (p= 0.002), total dose of HDR-BT > 20 Gy (p< 0.001), 3DHDR (p< 0.001), BED-HDR > 99 Gy1.5 (p<0.001) and BED-TT > 185 (p<0.001). On multivariate analysis the statistical significant predictive factors related to bC were RG (p< 0.001), HDR-BT > 20 Gy (p=0.008) and 3DHDR (p<0.001). Conclusions: we observed that the bC rates correlates with the generally accepted risk factors described in the literature. Dose escalation, evaluated through the BED, and the quality of planning of HDR-BT are also important predictive factors when treating prostate cancer.

Keywords :
high-dose rate brachytherapy, external beam radiotherapy, prostate cancer, RTOG-ASTRO Phoenix, biochemical failure, biochemical control

Date Deposited : 28 Jul 2011 11:05

Last Modified : 28 Jul 2011 11:05

Official URL: http://www.medsci.org/archive

Volume 5, Number 3, - 2008 , ISSN 1449-1907

Download:
Full Text Original
Abstract : pdf doc
Home | Peta Situs | Admissions | Student Research | E-Journal
Universitas Muhammadiyah Malang © 2011
Developed by Infokom UMM
Last Update : 13 December 2016 20:46Kumpulan file jurnal